website statistics
Spanish Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Return to news


Bagsværd, Denmark, 3 May 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.

The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.

Please find below a statement of such trading in shares issued by Novo Nordisk.

1 Details of the person discharging managerial responsibilities/person closely associated
a)Name of the Board member/Executive/Associated PersonDoug Langa
2 Reason for the notification
a)Position/statusExecutive Vice President, North America Operations
b)Initial notification/AmendmentInitial notification
3 Details of the issuer
a)NameNovo Nordisk A/S
b)LEI549300DAQ1CVT6CXN342
4 Details of the transaction(s)
a)Description of the financial instrument,
type of instrument,		Shares

 Identification codeNovo Nordisk B DK0060534915
b)Nature of the transactionSale of shares
c)







Price(s) and volume(s)













































































































































 Price(s)Volume(s) 
 DKK 808,10200 Shares 
 DKK 808,10204 Shares 
 DKK 807,9029 Shares 
 DKK 807,70110 Shares 
  DKK 807,902 Shares 
  DKK 807,9024 Shares 
  DKK 807,9095 Shares 
  DKK 807,9085 Shares 
  DKK 807,9070 Shares 
  DKK 807,60170 Shares 
  DKK 807,50179 Shares 
  DKK 807,05200 Shares 
  DKK 807,10185 Shares 
  DKK 807,05185 Shares 
  DKK 807,1093 Shares 
  DKK 807,4062 Shares 
  DKK 807,4027 Shares 
  DKK 807,5015 Shares 
  DKK 807,5015 Shares 
  DKK 807,5014 Shares 
  DKK 807,50169 Shares 
  DKK 807,60217 Shares 
  DKK 807,60115 Shares 
  DKK 807,5023 Shares 
  DKK 807,80494 Shares 
  DKK 807,8027 Shares 
  DKK 807,70495 Shares 
  DKK 807,804913 Shares 
  DKK 807,6038 Shares 
  DKK 807,5054 Shares 
  DKK 807,608 Shares 
  DKK 807,605 Shares 
  DKK 807,6085 Shares 
  DKK 807,50125 Shares 
  DKK 807,45230 Shares 
  DKK 807,6044 Shares 
  DKK 807,6022 Shares 
  DKK 807,60104 Shares 
  DKK 807,55870 Shares 
  DKK 807,7069 Shares 
  DKK 807,7046 Shares 
  DKK 808,0038 Shares 
  DKK 808,0020 Shares 
  DKK 808,0044 Shares 
  DKK 808,0087 Shares 
  DKK 808,3010 Shares 
  DKK 808,3017 Shares 
  DKK 808,3010 Shares 
  DKK 808,308 Shares 
  DKK 808,3062 Shares 
  DKK 808,3013 Shares 
  DKK 808,4027 Shares 
  DKK 808,4062 Shares 
  DKK 808,5027 Shares 
  DKK 808,5062 Shares 
  DKK 808,6024 Shares 
  DKK 808,603 Shares 
  DKK 808,6012 Shares 
  DKK 808,6062 Shares 
  DKK 808,6012 Shares 
  DKK 808,7027 Shares 
  DKK 808,7062 Shares 
  DKK 808,9027 Shares 
  DKK 808,9062 Shares 
  DKK 808,9027 Shares 
  DKK 808,9043 Shares 
  DKK 808,9019 Shares 
  DKK 808,701 Shares 
  DKK 808,6015 Shares 
     
d)Aggregated information
  • Aggregated volume
  • Price


11,000 shares
DKK 807.76
e)Date of the transaction2022-04-29
f)Place of the transactionNasdaq Copenhagen


1 Details of the person discharging managerial responsibilities/person closely associated
a)Name of the Board member/Executive/Associated PersonHenrik Ehlers Wulff
2 Reason for the notification
a)Position/statusExecutive Vice President,
Product Supply, Quality and IT
b)Initial notification/AmendmentInitial notification
3 Details of the issuer
a)NameNovo Nordisk A/S
b)LEI549300DAQ1CVT6CXN342
4 Details of the transaction(s)
a)Description of the financial instrument,
type of instrument,		Shares

 Identification codeNovo Nordisk B DK0060534915
b)Nature of the transactionSale of shares
c)







Price(s) and volume(s)







    
 Price(s)Volume(s) 
 DKK 815.006,346 shares 
    
    
d)Aggregated information
  • Aggregated volume
  • Price


6,346 shares
DKK 815.00
GlobeNewswire
By: GlobeNewswire - 03 May 2022
Return to news

Partners

Upcoming Life Sciences Events

  • April 2024
    • Pharma-Biotech Product & Company Valuation - An Introductory
    • Basel: Swiss Biotech Day 2024
    • London: BioTrinity 2024

Latest company news

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
18 Apr 2024 (GlobeNewswire)

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
18 Apr 2024 (GlobeNewswire)

deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
18 Apr 2024 (GlobeNewswire)

Biotechgate database

About Biotechgate
The Spanish Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com